盈康生命：目前重要子公司主要为圣诺医疗和优尼器械

Core Insights - Yingkang Life announced on August 26 that its key subsidiaries are Shengnuo Medical and Yuni Medical, with Shengnuo Medical achieving revenue of 97.23 million yuan in the first half of 2025, a year-on-year increase of 11.21%, and a net profit of 16.71 million yuan, up 28.70% [1] - Shengnuo Medical maintained its market share in a competitive environment, with a domestic market share of over 10% for infusion pumps, ranking third, and a similar ranking for mammography equipment with a market share of approximately 10% [1] - Yuni Medical reported revenue of 50.77 million yuan in the first half of 2025, a year-on-year increase of 12.59%, and a net profit of 15.58 million yuan, up 37.75% [1] - The collaboration between Shengnuo and Yuni has enabled the company to penetrate over 720 top-tier hospitals, achieving a coverage rate of over 40% in these hospitals [1]